Mishima Gerhart

No open positions remaining

Health Technology

Consumer Services

Profile

Mishima S.
Gerhart worked as Head-Regulatory Affairs at Genzyme Corp.
from 2014 to 2016.
From 2014 to 2020, served as Vice President & Head-Regulatory Affairs at Sanofi.
Held the position of Chief Regulatory Officer & Head-Quality at Taysha Gene Therapies, Inc. Also worked as Chief Regulatory Officer at Pliant Therapeutics, Inc. Completed undergraduate studies at Kutztown University of Pennsylvania and graduate studies at Temple University (Pennsylvania).

Former positions of Mishima Gerhart

Companies	Position	End
SANOFI	General Counsel	01/06/2020
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	General Counsel	01/01/2016
PLIANT THERAPEUTICS, INC.	General Counsel	-
TAYSHA GENE THERAPIES, INC.	General Counsel	-

See the detail of Mishima Gerhart's experience

Training of Mishima Gerhart

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mishima Gerhart's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Health Technology
Sanofi Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines	Health Technology
Kutztown University of Pennsylvania Kutztown University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Temple University (Pennsylvania) Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Pliant Therapeutics, Inc. Pliant Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company focuses on discovering and developing novel therapies for the treatment of fibrosis	Health Technology
Taysha Gene Therapies, Inc. Taysha Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes adeno-associated viruses-based gene therapies for the treatment of monogenic diseases of the central nervous system	Health Technology